Porth, I. (2024). Long-term response to trastuzumab in patients with HER2-positive advanced gastric or gastroesophageal adenocarcinoma. https://doi.org/10.11588/heidok.00034645
Chicago Style (17th ed.) CitationPorth, Isabel. Long-term Response to Trastuzumab in Patients with HER2-positive Advanced Gastric or Gastroesophageal Adenocarcinoma. Heidelberg, 2024. https://doi.org/10.11588/heidok.00034645.
MLA (9th ed.) CitationPorth, Isabel. Long-term Response to Trastuzumab in Patients with HER2-positive Advanced Gastric or Gastroesophageal Adenocarcinoma. 2024. https://doi.org/10.11588/heidok.00034645.
Warning: These citations may not always be 100% accurate.